Paralemmin anticorps (N-Term)
Aperçu rapide pour Paralemmin anticorps (N-Term) (ABIN928838)
Antigène
Voir toutes Paralemmin (PALM) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Purified
-
Immunogène
- PALM antibody was raised in rabbit using the N terminal of PALM as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
PALM Blocking Peptide, (ABIN940270), is also available for use as a blocking control in assays to test for specificity of this PALM antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- Paralemmin (PALM)
-
Autre désignation
- PALM
-
Sujet
- This gene encodes a member of the paralemmin protein family. The product of this gene is a prenylated and palmitoylated phosphoprotein that associates with the cytoplasmic face of plasma membranes and is implicated in plasma membrane dynamics in neurons and other cell types. Several alternatively spliced transcript variants have been identified, but the full-length nature of only two transcript variants has been determined. Synonyms: Polyclonal PALM antibody, Anti-PALM antibody, paralemmin antibody, KIAA0270 antibody.
-
Pathways
- cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling
Antigène
-